Clinical trial
The Role of Colchicine as Anti-Inflammatory Treatment in Patients With HFpEF: A Prospective Study
NCT06837623 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Colchicine as Anti-Inflammatory Treatment in Patients With HFpEF: A Prospective Study
- Lead sponsor
- Cairo University
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- July 1, 2024
- Completion date
- March 1, 2025
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hfpef - heart failure with preserved ejection fraction